Rickettsial Diseases

Rickettsial diseases in dogs encompass a group of serious bacterial infections caused by obligate intracellular organisms transmitted primarily through tick bites. The main rickettsial diseases affecting dogs include ehrlichiosis, anaplasmosis, and Rocky Mountain spotted fever, each caused by different bacterial species but sharing similar transmission routes, clinical presentations, and treatment approaches. These infections have become increasingly recognized as significant causes of illness in dogs, particularly in regions with high tick populations. Understanding rickettsial diseases is essential for dog owners in endemic areas, as early recognition and treatment dramatically improve outcomes while delays can lead to severe, potentially fatal complications.

The pathogenesis of rickettsial infections involves bacterial invasion and multiplication within host cells, distinguishing these organisms from most bacteria that grow in tissues or body fluids. Different rickettsial species target different cell types, with Ehrlichia canis and Ehrlichia ewingii infecting white blood cells, Anaplasma phagocytophilum infecting neutrophils, and Rickettsia rickettsii infecting vascular endothelial cells lining blood vessels. This intracellular lifestyle protects the bacteria from many immune defenses and antibiotics, contributing to disease persistence. The body's inflammatory response to infection causes much of the clinical disease, with vascular damage, immune-mediated cell destruction, and cytokine release producing symptoms.

Clinical manifestations of rickettsial diseases vary by specific pathogen but commonly include fever, lethargy, decreased appetite, and joint pain. Ehrlichiosis may present acutely with fever and malaise or chronically with bone marrow suppression causing bleeding disorders and anemia. Anaplasmosis typically causes acute illness with fever and joint pain. Rocky Mountain spotted fever produces severe vasculitis with fever, edema, and bleeding tendencies. Many dogs develop low platelet counts (thrombocytopenia) that can cause bruising and hemorrhage. The nonspecific nature of early symptoms can delay diagnosis, making awareness of tick exposure and endemic areas important for prompt recognition.

Treatment of rickettsial diseases relies on antibiotics, particularly doxycycline, which effectively penetrates cells to reach intracellular bacteria. Most dogs respond rapidly to appropriate therapy when treatment begins early, with fever resolving within one to two days and gradual improvement in other symptoms over one to two weeks. However, dogs with chronic ehrlichiosis or severe Rocky Mountain spotted fever may have more protracted recovery and potential long-term complications. Prevention through tick control remains the most effective strategy for avoiding these potentially serious infections. Regular use of veterinarian-recommended tick preventatives and minimizing tick habitat exposure significantly reduce infection risk.

The direct causes of rickettsial diseases are bacteria belonging to the order Rickettsiales, specifically organisms in the genera Ehrlichia, Anaplasma, and Rickettsia. Ehrlichia canis, transmitted by the brown dog tick (Rhipicephalus sanguineus), causes canine monocytic ehrlichiosis. Ehrlichia ewingii, carried by the Lone Star tick (Amblyomma americanum), causes canine granulocytic ehrlichiosis. Anaplasma phagocytophilum, transmitted by Ixodes ticks including the deer tick, causes canine granulocytic anaplasmosis. Anaplasma platys infects platelets and is transmitted by the brown dog tick. Rickettsia rickettsii, transmitted by American dog tick and Rocky Mountain wood tick, causes Rocky Mountain spotted fever. Understanding the specific pathogen helps predict clinical course and geographic distribution.

Genetic predisposition to rickettsial diseases has not been definitively established, though some evidence suggests certain breeds may develop more severe disease when infected. German Shepherds appear to have increased susceptibility to severe, chronic ehrlichiosis, possibly related to breed-associated immune characteristics. Other breed predispositions are less clearly documented. Dogs with inherited immune deficiencies might theoretically have altered response to rickettsial infection, though such dogs often succumb to other infections before rickettsial exposure. Genetic factors influencing tick attachment or grooming behavior could indirectly affect exposure risk but have not been well characterized.

Environmental and lifestyle factors profoundly influence rickettsial disease risk through determining tick exposure. Geographic location is paramount, with different diseases prevalent in different regions corresponding to their tick vector distribution. Dogs living in or traveling to tick-endemic areas face elevated risk. Outdoor lifestyle, particularly in wooded, brushy, or grassy habitats, increases tick encounters. Hunting dogs, hiking companions, and dogs with access to wildlife areas have substantial exposure. Seasonal factors influence risk, with peak transmission occurring during warm months when tick activity is highest, though in mild climates year-round transmission occurs. Urban dogs with limited outdoor access have lower but not zero risk.

Tick exposure and attachment are the critical risk factors for rickettsial disease acquisition. Ticks acquire rickettsial organisms by feeding on infected wildlife reservoirs, then transmit bacteria to dogs during subsequent blood meals. Transmission timing varies by pathogen, with some requiring prolonged attachment of twenty-four to forty-eight hours while others transmit more rapidly. Dogs without effective tick prevention have dramatically higher infection rates than those receiving regular preventative treatment. Previous rickettsial infection does not provide complete immunity, and reinfection can occur. Co-infection with multiple tick-borne pathogens is common in heavily exposed dogs, potentially producing more complex clinical presentations.

The mechanism of disease development following tick-transmitted infection involves bacterial invasion and multiplication within target cells. After tick inoculation, rickettsial organisms spread through blood and lymph to reach susceptible cells throughout the body. The bacteria enter cells through receptor-mediated uptake and replicate within intracellular compartments. Infected cell destruction releases bacteria to infect additional cells, while simultaneously triggering immune responses. The immune system's attempts to eliminate infection cause inflammation and tissue damage that produce clinical signs. Vascular endothelial cell infection, characteristic of Rocky Mountain spotted fever, causes vasculitis with widespread effects. Bone marrow infection can suppress blood cell production. The chronic carrier state that develops in some ehrlichiosis cases represents ongoing immune-pathogen interaction.

Early warning signs of rickettsial diseases are often subtle and nonspecific, resembling many other canine illnesses. Initial symptoms typically develop one to three weeks following infected tick bite, though this incubation period varies. Early signs include mild lethargy or decreased enthusiasm for usual activities, subtle reduction in appetite that owners may initially overlook, and minor temperature elevation that goes undetected without measurement. Some dogs show mild joint stiffness that improves with movement and might be attributed to sleeping in an awkward position or minor injury. These vague early signs often go unrecognized, particularly in dogs with unknown tick exposure, until more obvious symptoms develop.

Common symptoms of rickettsial diseases include fever, which may be high (104-106°F) and causes obvious illness including lethargy, loss of appetite, and depression. Decreased appetite progresses from reduced enthusiasm for food to complete anorexia in more severe cases. Weight loss occurs with prolonged illness. Lymph node enlargement may be noted as firm swellings under the jaw, in front of shoulders, or behind knees. Joint pain causes stiffness, reluctance to rise, bunny-hopping gait, and reluctance to climb stairs or jump. Muscle pain produces generalized tenderness and resistance to handling. Discharge from eyes and nose may occur in some dogs.

Behavioral changes in dogs with rickettsial disease reflect both fever and systemic illness. Lethargy is nearly universal, with dogs sleeping more, showing decreased interest in walks or play, and having reduced interaction with family members. Painful joints and muscles may cause dogs to resist petting or become uncharacteristically snappy when touched. Some dogs seek isolation, hiding or staying in dark quiet areas. Others become clingy, seeking comfort from owners. Exercise intolerance develops, with dogs reluctant or unable to complete normal walks. Changes in drinking habits may include increased thirst from fever or decreased drinking from malaise. House-trained dogs may have accidents due to weakness or urgency.

Physical signs of rickettsial diseases vary somewhat by specific infection but share common features. Petechiae (tiny red spots) and ecchymoses (bruises) on gums, skin, and whites of eyes reflect low platelet counts and bleeding tendencies. Pale gums indicate anemia from red blood cell destruction or bone marrow suppression. Enlarged spleen may be palpable in the abdomen. Limb edema, particularly affecting the legs or scrotum, occurs with Rocky Mountain spotted fever. Eye abnormalities including redness, discharge, and retinal changes may be present. Some dogs develop neurological signs including head tilt, incoordination, or seizures with central nervous system involvement.

Symptom progression in rickettsial disease follows acute, subclinical, and chronic phases depending on the specific pathogen and host response. Acute ehrlichiosis typically lasts two to four weeks if untreated, with symptoms potentially resolving spontaneously as dogs enter subclinical phase. The subclinical phase may last months to years with no obvious illness despite ongoing infection. Chronic ehrlichiosis emerges when immune suppression produces severe bone marrow damage with life-threatening bleeding and infection susceptibility. Anaplasmosis usually remains acute without developing chronic stages. Rocky Mountain spotted fever progresses rapidly over days, with severe cases developing shock and organ failure without prompt treatment. Understanding these patterns helps recognize different presentations.

Emergency symptoms requiring immediate veterinary care include signs of severe bleeding such as bloody urine, black tarry stool, profuse nosebleeds, or extensive bruising. Extreme weakness or collapse suggests severe anemia or impending shock. Respiratory distress with rapid labored breathing indicates potential lung hemorrhage or fluid accumulation. High fever (over 105°F) with severe depression represents medical emergency. Neurological symptoms including seizures, inability to walk, or altered consciousness require urgent evaluation. Sudden onset of significant limb or facial swelling in endemic areas warrants immediate attention. Any rapid deterioration in previously stable dogs demands emergency care.

Initial veterinary examination for suspected rickettsial disease involves comprehensive assessment combined with careful history taking about tick exposure. The physical examination evaluates temperature, checking for fever that characterizes these infections. Examination of mucous membranes assesses for pallor indicating anemia and petechiae suggesting bleeding disorders. Lymph nodes are palpated for enlargement. Joint evaluation checks for swelling, warmth, and pain response. The abdomen is palpated for splenic enlargement. Eye examination may reveal abnormalities. History taking explores recent tick exposure, geographic travel, tick prevention use, timeline of symptoms, and any similar previous episodes. Knowledge of endemic areas helps raise appropriate suspicion.

Laboratory testing provides crucial diagnostic information for rickettsial diseases. Complete blood count commonly reveals thrombocytopenia (low platelets), which occurs in most rickettsial infections and is often an early clue. Anemia and low white blood cell counts may be present. Serum chemistry may show elevated liver enzymes and low albumin. The combination of thrombocytopenia with clinical signs in a tick-exposed dog strongly suggests rickettsial disease. Urinalysis may show protein loss reflecting vascular damage. Coagulation testing assesses bleeding risk. These baseline tests also help monitor treatment response and identify complications.

Specific diagnostic tests confirm rickettsial infection and identify the causative organism. Serologic testing detects antibodies against specific pathogens using tests like indirect fluorescent antibody (IFA) or ELISA methods. Point-of-care tests are available for some diseases allowing rapid in-clinic screening. However, antibodies take one to two weeks to develop, so very early infections may test negative. A four-fold rise in antibody titer between acute and convalescent samples provides stronger evidence. PCR (polymerase chain reaction) testing detects pathogen DNA in blood and can identify infection before antibody development. Blood smear examination occasionally reveals intracellular organisms (morulae) in infected white blood cells or platelets, providing rapid diagnosis when present.

Differential diagnosis for rickettsial diseases includes other tick-borne infections and conditions producing similar clinical signs. Lyme disease causes joint pain and fever but typically lacks thrombocytopenia. Babesiosis causes anemia and fever with tick transmission. Immune-mediated thrombocytopenia produces low platelets and bleeding without fever. Lymphoma and other cancers can cause lymph node enlargement, fever, and blood count changes. Autoimmune diseases may produce similar multi-system presentations. Acute leptospirosis shares fever, joint pain, and organ involvement. The combination of history, clinical signs, routine laboratory findings, and specific testing usually allows accurate diagnosis. Co-infection with multiple tick-borne pathogens should be considered in heavily exposed dogs with atypical presentations.

Emergency and immediate treatment for severely ill dogs with rickettsial disease focuses on stabilization while initiating definitive antibiotic therapy. Dogs with life-threatening anemia may require blood transfusions to restore oxygen-carrying capacity. Intravenous fluid therapy supports circulation and helps maintain blood pressure in dogs showing signs of shock. Dogs with severe bleeding may need platelet transfusions, though these are not universally available. Oxygen supplementation helps dogs with respiratory compromise. Pain management addresses joint and muscle pain. Antibiotic therapy is started immediately when rickettsial disease is strongly suspected, without waiting for confirmatory test results, as treatment delay worsens outcomes.

Antibiotic therapy with doxycycline represents the cornerstone of treatment for all canine rickettsial diseases. Doxycycline is highly effective against Ehrlichia, Anaplasma, and Rickettsia species, achieving excellent intracellular concentrations to reach these obligate intracellular pathogens. Standard dosing is 5 mg/kg twice daily or 10 mg/kg once daily, administered orally for 28 days. Dogs unable to take oral medication initially may receive intravenous doxycycline or minocycline until able to transition to oral therapy. Response to treatment is often rapid, with fever resolving within 24-48 hours and improvement in other symptoms within the first week. However, completing the full treatment course is essential to prevent relapse and chronic carrier states.

Alternative antibiotics are occasionally used when doxycycline cannot be tolerated or is contraindicated. Minocycline has similar efficacy and may cause less gastrointestinal upset than doxycycline. Tetracycline can be used but requires more frequent dosing. Chloramphenicol is effective but carries risk of bone marrow suppression and requires careful monitoring. Fluoroquinolones have some activity against rickettsial organisms but are generally considered less effective than tetracyclines. In very young puppies where tetracyclines might affect tooth development, the benefit of treatment typically outweighs this concern given the seriousness of rickettsial infection.

Supportive care measures complement antibiotic therapy to address specific complications. Dogs with severe thrombocytopenia may receive immunosuppressive doses of corticosteroids, particularly when immune-mediated platelet destruction contributes to bleeding. Gastroprotectants help prevent gastrointestinal ulceration in dogs receiving corticosteroids or with bleeding tendencies. Nutritional support maintains strength during recovery, with appetite stimulants or assisted feeding if needed. Activity restriction prevents trauma and bleeding in dogs with low platelets. Pain management keeps dogs comfortable. Fluid therapy maintains hydration. Monitoring for transfusion reactions is important in dogs receiving blood products.

Treatment of chronic ehrlichiosis presents additional challenges compared to acute infection. Dogs with bone marrow suppression may require prolonged antibiotic courses extending beyond 28 days. Immunosuppressive therapy may be needed for immune-mediated complications. Some dogs require multiple blood transfusions during treatment. Complete blood count recovery may take months even with successful treatment. Dogs with severe bone marrow damage may not fully recover normal blood cell production. Prognosis for chronic ehrlichiosis is more guarded than for acute infection, though many dogs respond to aggressive treatment.

Treatment decisions balance disease severity, specific diagnosis when available, and individual patient factors. Most dogs with acute rickettsial disease respond well to outpatient doxycycline therapy with supportive care at home. Dogs with severe thrombocytopenia, significant anemia, or systemic complications benefit from hospitalization until stable. Starting treatment empirically based on clinical suspicion while awaiting diagnostic confirmation is appropriate given the good response to doxycycline and risks of treatment delay. Cost considerations are relevant for prolonged treatment courses and supportive care needs. The generally excellent response of acute rickettsial disease to treatment makes prompt therapy rewarding.

Recovery timeline for rickettsial diseases depends on disease severity, specific pathogen, and promptness of treatment initiation. Dogs with acute infections treated early often show dramatic improvement within the first few days of antibiotic therapy, with fever resolving in 24-48 hours. Appetite and energy level typically improve within the first week. Complete resolution of clinical signs usually occurs within two to four weeks of treatment, coinciding with the standard antibiotic course. Laboratory abnormalities including thrombocytopenia and anemia generally improve within the first two weeks, with complete normalization taking several weeks to months in some cases. Dogs with chronic ehrlichiosis or severe Rocky Mountain spotted fever have more prolonged recovery periods.

Post-treatment care involves completing the full antibiotic course and monitoring for adequate response. Even dogs feeling significantly better must continue doxycycline for the full 28 days to prevent relapse and eliminate infection. Activity restriction during recovery helps prevent bleeding complications in dogs with persistently low platelets. Follow-up blood work, typically one to two weeks after starting treatment and again after completing therapy, confirms improvement in blood counts. Dogs with initially severe disease may need more frequent monitoring. Appetite support and good nutrition aid recovery. Avoiding tick exposure during and after treatment prevents reinfection.

Prognostic factors for rickettsial disease recovery include disease stage at diagnosis, specific pathogen involved, severity of complications, and host immune status. Acute ehrlichiosis and anaplasmosis carry excellent prognosis with appropriate treatment, with greater than 95% of dogs achieving full recovery. Early-treated Rocky Mountain spotted fever also has good prognosis, though delays of even a few days significantly worsen outcomes. Chronic ehrlichiosis has more variable prognosis depending on the degree of bone marrow damage; some dogs recover fully while others have permanent cytopenias or succumb despite treatment. Dogs developing organ failure, severe bleeding, or neurological complications have more guarded prognoses.

Long-term outlook for dogs recovered from rickettsial disease is generally excellent for those achieving complete recovery. Most dogs return to normal activity and health with no lasting effects from their infection. Some dogs with ehrlichiosis remain seropositive (have detectable antibodies) for years after treatment without clinical significance. Dogs recovered from one rickettsial infection do not develop complete immunity and can be reinfected if re-exposed to infected ticks. Lifelong tick prevention is strongly recommended to prevent recurrence. Dogs with residual bone marrow damage from chronic ehrlichiosis may require ongoing monitoring and supportive care. Understanding that recovery does not equal future immunity emphasizes the importance of consistent tick prevention.

Primary prevention of rickettsial diseases centers on minimizing tick exposure and using effective tick preventatives. Year-round tick prevention using veterinarian-recommended products is the single most effective preventive measure. Available products include topical applications, oral medications, and tick collars, with various products providing different durations of protection. Tick preventatives work by killing or repelling ticks before disease transmission can occur. Product selection should consider local tick species, lifestyle factors, and individual dog characteristics; veterinarians can recommend optimal choices. Consistent application following product instructions ensures continuous protection without gaps that allow infection.

Environmental tick control reduces exposure in home environments. Maintaining short grass and removing brush and leaf litter eliminates tick habitat around homes. Creating barrier zones of gravel or wood chips between lawns and wooded areas reduces tick migration into yards. Treating yards with appropriate acaricides can reduce tick populations, though environmental concerns must be balanced. Fencing to exclude deer and other wildlife reservoirs removes tick hosts from immediate environments. Regular property maintenance minimizes areas where ticks thrive. These measures complement but do not replace individual animal prevention.

Lifestyle modifications reduce tick encounters during outdoor activities. Avoiding known tick-infested areas during peak activity seasons provides protection. Staying on cleared trails rather than walking through brush or tall grass limits exposure during hikes. Checking dogs thoroughly for ticks after outdoor activities allows removal before disease transmission, which requires hours of attachment for most pathogens. Bathing dogs after potential exposure may help remove unattached ticks. Using tick-repellent products before outdoor excursions in high-risk areas provides additional protection. Understanding local tick seasons helps time prevention efforts.

Health maintenance supports immune function and overall resistance. Regular veterinary examinations monitor health status and provide opportunities for tick prevention counseling. Maintaining optimal nutrition and body condition supports immune competence. Managing concurrent health conditions optimizes overall resistance. Prompt veterinary evaluation of any illness in tick-exposed dogs allows early treatment if rickettsial disease develops. Knowing local disease prevalence helps owners and veterinarians maintain appropriate suspicion.

Early intervention when exposure occurs or symptoms develop minimizes disease impact. Prompt tick removal using proper technique (grasping close to skin and pulling steadily) reduces transmission risk for ticks found attached. Saving removed ticks for identification can help guide monitoring. Recognizing early symptoms of rickettsial disease allows prompt veterinary evaluation and treatment initiation before severe complications develop. Dogs in endemic areas with unexplained fever, lethargy, or joint pain should be evaluated for tick-borne diseases. Starting treatment based on clinical suspicion while awaiting test results prevents treatment delays in strongly suspected cases.

Daily management of dogs being treated for rickettsial disease requires attention to medication administration, monitoring, and activity modification. Doxycycline should be given with food to reduce gastrointestinal upset, a common side effect. Avoiding dairy products around dosing time prevents calcium interference with absorption. Medication timing should be consistent to maintain effective blood levels throughout treatment. Daily observation notes appetite, energy level, and any concerning symptoms. Dogs with low platelet counts require careful handling to prevent trauma and bleeding. Temperature monitoring at home if instructed helps track fever resolution.

Home environment during treatment should minimize injury risk for dogs with bleeding tendencies. Removing obstacles that could cause falls or bumps protects dogs with thrombocytopenia. Soft bedding provides comfortable rest. Preventing rough play with other pets or children avoids trauma. Blocking access to stairs may be appropriate for weak or uncoordinated dogs. Maintaining comfortable temperatures supports dogs fighting infection. Easy access to water encourages hydration. Quiet, calm environments promote rest and recovery.

Quality of life considerations during treatment balance rest needs with mental wellbeing. While activity restriction is important for dogs with significant thrombocytopenia, mental stimulation through calm interaction, gentle petting, and low-key engagement maintains emotional health. Dogs feeling better as treatment progresses naturally want increased activity, requiring gradual controlled return to normal rather than immediate resumption of strenuous exercise. Maintaining normal feeding routines and favorite resting spots provides comfort and normalcy. Pain management ensures physical comfort throughout recovery.

Ongoing monitoring during and after treatment tracks recovery and identifies complications. Regular blood count rechecks document platelet and red blood cell recovery. Persistent thrombocytopenia after several weeks of treatment may indicate treatment failure, incorrect diagnosis, or immune-mediated complications requiring additional therapy. Watching for recurrence of symptoms after completing treatment catches relapse early. Post-treatment titers may help confirm adequate treatment response. Long-term monitoring of dogs recovered from chronic ehrlichiosis ensures stable blood counts. Documentation of treatment and recovery informs future veterinary care.

Lifelong prevention after recovery protects against reinfection, which remains possible despite previous infection. Consistent year-round tick preventative use provides ongoing protection. Annual or more frequent tick-borne disease screening may be recommended for dogs in endemic areas. Owner vigilance for early symptoms of tick-borne disease allows prompt evaluation of any concerning signs. Understanding that recovered dogs remain susceptible to new infection reinforces the importance of prevention. Educating family members about tick prevention and disease recognition extends protective awareness. Connecting with veterinary team for prevention guidance ensures optimal protection strategies.

German Shepherds have documented increased susceptibility to severe and chronic ehrlichiosis, potentially developing more significant disease than other breeds following infection. This increased vulnerability appears related to breed-specific immune characteristics that result in more pronounced bone marrow suppression and higher rates of progression to chronic disease. German Shepherds with ehrlichiosis should be monitored particularly closely and treated aggressively. Other breeds have not been clearly shown to have inherently increased susceptibility to rickettsial disease severity, though any dog can develop serious illness with these infections.

Breed characteristics influencing lifestyle and exposure affect rickettsial disease risk more than inherent susceptibility. Hunting breeds including Labrador Retrievers, Beagles, and various hound breeds spend significant time in tick habitat and have elevated exposure risk. Working breeds used for outdoor activities face similar increased exposure. Breeds commonly living in endemic areas, particularly southeastern and south-central United States for ehrlichiosis, have higher geographic risk. Small breeds are not protected by size; all dogs are susceptible to tick attachment and infection. Mixed breed dogs face the same risks as purebred dogs depending on their lifestyle and environment.

Breed-specific recommendations focus on appropriate prevention for lifestyle rather than inherent susceptibility. All dogs in tick-endemic areas should receive consistent tick prevention regardless of breed. German Shepherds with suspected tick-borne disease warrant aggressive diagnostic workup and treatment given their susceptibility to severe disease. Working and hunting dogs benefit from particularly rigorous tick prevention programs. Annual tick-borne disease screening can be considered for dogs in endemic areas with high outdoor exposure. Breed selection considerations should include willingness to commit to tick prevention for breeds commonly used in high-exposure activities.

Commonly co-occurring conditions with rickettsial diseases include other tick-borne infections acquired through the same vector exposure. Co-infection with multiple tick-borne pathogens occurs frequently in heavily exposed dogs, as a single tick may carry multiple organisms or dogs may receive bites from multiple infected ticks. Lyme disease co-infection is common in areas where both diseases occur. Babesiosis may co-occur, adding hemolytic anemia to the clinical picture. Bartonellosis is increasingly recognized as a canine tick-borne infection. Co-infections may produce more severe or complex clinical presentations than single infections. Testing for multiple tick-borne diseases is appropriate for dogs with significant tick exposure and compatible symptoms.

Conditions producing similar symptoms to rickettsial diseases require differentiation for appropriate treatment. Immune-mediated thrombocytopenia causes low platelets and bleeding without the fever and joint pain typical of rickettsial disease. Immune-mediated hemolytic anemia produces anemia but through different mechanism than rickettsial infection. Lyme disease shares tick transmission and joint involvement but usually lacks thrombocytopenia. Lymphoma and leukemia can cause fever, lymph node enlargement, and blood count abnormalities. Systemic lupus erythematosus produces multi-system inflammation mimicking infectious disease. Thorough diagnostic evaluation including specific testing for tick-borne pathogens differentiates these conditions.

Potential complications of rickettsial diseases arise from the primary infection and host responses. Severe thrombocytopenia can cause life-threatening hemorrhage including gastrointestinal bleeding, pulmonary hemorrhage, or bleeding into body cavities. Profound anemia may require transfusion and can cause cardiac complications. Rocky Mountain spotted fever vasculitis can lead to organ damage, particularly affecting kidneys and nervous system. Chronic ehrlichiosis produces bone marrow failure with pancytopenia leaving dogs susceptible to secondary infections. Neurological complications can cause permanent deficits in some dogs. Secondary infections may develop in immunocompromised dogs. Early, appropriate treatment minimizes complication risk while delays increase likelihood of severe sequelae.